Chang Shuwei, Zhang Minghui, Liu Chang, Li Mingyu, Lou Yuefen, Tan Hexin
Department of Pharmacy, Shanghai Fourth People's Hospital Affiliated to Tongji University, Shanghai, China.
Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai, China.
Cell Death Discov. 2025 Aug 1;11(1):358. doi: 10.1038/s41420-025-02654-y.
Ferroptosis, an iron-dependent form of regulated cell death driven by redox dysregulation, is defined by iron overload, reactive oxygen species overproduction, and subsequent peroxidation of polyunsaturated fatty acid-containing phospholipids, notably glycerophospholipids. This review comprehensively delineates the enzymatic such as lipoxygenases and non-enzymatic including Fenton reaction pathways governing glycerophospholipid peroxidation. Furthermore, we systematically dissect fine regulation of iron ions, including absorption, transport, and redox state transition. Given pathophysiological relevance of ferroptosis to numerous diseases, especially neurodegenerative disorders and various cancers, we evaluate emerging therapeutic strategies targeting key ferroptosis nodes, with a primary focus on the key enzymes involved in lipid peroxidation, transferrin receptor-mediated endocytosis mechanism and traditional Chinese medicine. Our work provides a direction for advancing ferroptosis research and developing combinatorial therapies that synergize ferroptosis induction with conventional treatments.
铁死亡是一种由氧化还原失调驱动的铁依赖性调节性细胞死亡形式,其特征是铁过载、活性氧过度产生以及随后含多不饱和脂肪酸的磷脂(尤其是甘油磷脂)的过氧化。本综述全面描述了诸如脂氧合酶等酶促途径以及包括芬顿反应在内的非酶促途径,这些途径控制着甘油磷脂的过氧化。此外,我们系统地剖析了铁离子的精细调节,包括吸收、运输和氧化还原状态转变。鉴于铁死亡与众多疾病(尤其是神经退行性疾病和各种癌症)的病理生理相关性,我们评估了针对关键铁死亡节点的新兴治疗策略,主要关注参与脂质过氧化的关键酶、转铁蛋白受体介导的内吞机制和中药。我们的工作为推进铁死亡研究以及开发将铁死亡诱导与传统治疗协同作用的联合疗法提供了方向。
Cell Death Discov. 2025-8-1
Redox Biol. 2024-9
Int J Biol Macromol. 2025-6-22
Phytomedicine. 2024-7-25
Signal Transduct Target Ther. 2024-10-14
Chem Biol Drug Des. 2024-12
Eur J Med Chem. 2025-2-5
Front Endocrinol (Lausanne). 2024-11-12
J Ethnopharmacol. 2025-1-13
Biochem Biophys Res Commun. 2024-12-3
Int Immunopharmacol. 2024-12-25
Circ Res. 2024-11-8